KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Cash & Equivalents: 2011-2025

Historic Cash & Equivalents for Zoetis (ZTS) over the last 14 years, with Sep 2025 value amounting to $2.1 billion.

  • Zoetis' Cash & Equivalents rose 21.59% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 21.59%. This contributed to the annual value of $2.0 billion for FY2024, which is 2.65% down from last year.
  • Latest data reveals that Zoetis reported Cash & Equivalents of $2.1 billion as of Q3 2025, which was up 45.23% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Zoetis' Cash & Equivalents registered a high of $3.7 billion during Q2 2021, and its lowest value of $1.4 billion during Q2 2025.
  • In the last 3 years, Zoetis' Cash & Equivalents had a median value of $1.8 billion in 2023 and averaged $1.8 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 84.62% in 2021, then tumbled by 43.00% in 2023.
  • Quarterly analysis of 5 years shows Zoetis' Cash & Equivalents stood at $3.5 billion in 2021, then climbed by 2.75% to $3.6 billion in 2022, then plummeted by 43.00% to $2.0 billion in 2023, then declined by 2.65% to $2.0 billion in 2024, then increased by 21.59% to $2.1 billion in 2025.
  • Its Cash & Equivalents was $2.1 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.7 billion in Q1 2025.